Infinitus Secures Inclusion in Australia’s Therapeutic Goods List
Infinitus celebrates a significant milestone as its proprietary patented Folium Cyclocarya Paliurus Extract gains approval for inclusion in the Therapeutic Goods Administration of Australia (TGA) list. This approval grants Infinitus the green light for research and development, as well as the sale of complementary medicines featuring this ingredient in the Australia and New Zealand regions.
The inclusion on the TGA list underscores the ingredient’s compliance with the organization’s rigorous regulatory standards, having successfully passed comprehensive toxicological safety assessments. Notably, less than 40% of applicants received TGA approval in the year 2021, highlighting the exclusivity and stringent criteria of this recognition.
Folium Cyclocarya Paliurus Extract holds a pivotal role in Infinitus’s S-Harmony Herbal Vege Capsules, a key component in the company’s holistic approach aimed at assisting consumers in maintaining healthy blood glucose levels.
Expressing their commitment to excellence, Infinitus stated, “As we progress, Infinitus will remain committed to producing high-quality Chinese herbal products, while advocating the premium Chinese health regimen, co-creating healthier and happier lives for all.” This achievement reinforces Infinitus’s dedication to advancing quality herbal solutions and contributing to the well-being of individuals.